Nitrazolam

From Wikipedia, the free encyclopedia
Jump to navigation Jump to search
Nitrazolam
Nitrazolam.svg
Legal status
Legal status
Identifiers
CAS Number
PubChem CID
ChemSpider
UNII
Chemical and physical data
FormulaC17H13N5O2
Molar mass319.32 g·mol−1
3D model (JSmol)

Nitrazolam is a benzodiazepine[1] that has been sold online as a designer drug.[2][3]

It is closely related to clonazolam, only differing by the removal of a chlorine group at the benzene ring.

A study in mice indicated that nitrazolam can be several times more potent than diazepam as an antagonist of electroshock-induced tonic-extensor convulsions but less potent than diazepam at preventing the righting reflex.[4]

Nitrazolam has been used as an example compound to demonstrate the microscale synthesis of reference materials utilizing polymer‐supported reagents.[5]

Legal Status[edit]

United Kingdom[edit]

In the UK, nitrazolam has been classified as a Class C drug by the May 2017 amendment to The Misuse of Drugs Act 1971 along with several other designer benzodiazepine drugs.[6]

See also[edit]

References[edit]

  1. ^ Jackson B. Hester, Jr (19 October 1976). "Patent US3987052 - 6-Phenyl-4H-s-triazolo[4,3-a][1,4]benzodiazepines". The Upjohn Company.
  2. ^ "Nitrazolam". New Synthetic Drugs Database.
  3. ^ Moosmann, Bjoern; Bisel, Philippe; Franz, Florian; Huppertz, Laura M.; Auwärter, Volker (2016). "Characterization and in vitro phase I microsomal metabolism of designer benzodiazepines – an update comprising adinazolam, cloniprazepam, fonazepam, 3-hydroxyphenazepam, metizolam, and nitrazolam". Journal of Mass Spectrometry. 51: 1080–1089. doi:10.1002/jms.3840. ISSN 1096-9888. PMID 27535017 – via Wiley Online Library.
  4. ^ Jackson B. Hester Jr.; Allan D. Rudzik; Bharat V. Kamdar (November 1971). "6-Phenyl-4H-s-triazolo[4,3-a] [1,4]benzodiazepines which have central nervous system depressant activity". Journal of Medicinal Chemistry. 14 (11): 1078–1081. doi:10.1021/jm00293a015. PMID 5165540.
  5. ^ Dowling, Geraldine; Kavanagh, Pierce V.; Eckhardt, Hans-Georg; Twamley, Brendan; Hessman, Gary; McLaughlin, Gavin; O'Brien, John; Brandt, Simon D. (2018-04-24). "An approach to shortening the timeframe between the emergence of new compounds on the drugs market and the availability of reference standards: The microscale syntheses of nitrazolam and clonazolam for use as reference materials, utilizing polymer-support". Drug Testing and Analysis. doi:10.1002/dta.2383. ISSN 1942-7603.
  6. ^ "The Misuse of Drugs Act 1971 (Amendment) Order 2017".